Arcadia Biosciences (RKDA) Equity Income (2014 - 2022)

Arcadia Biosciences (RKDA) reported Equity Income of $1.1 million for Q2 2022, up 312.31% quarter-over-quarter from -$536000.0 in Q2 2014.

Arcadia Biosciences (RKDA) Equity Income (2014 - 2022) Analysis & Trends

Arcadia Biosciences has reported Equity Income for 2 years, with the latest figure at $1.1 million in Q2 2022.

For the quarter ending Q2 2022, Equity Income changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2023 stood at $1.1 million (changed 0.0% YoY), and the FY2022 full-year result was $1.1 million, changed N/A from the prior year.
Equity Income for Q2 2022 stood at $1.1 million, up from -$536000.0 in the prior quarter.
The five-year high for Equity Income was $1.1 million in Q2 2022, with the low at $1.1 million in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Equity Income (Qtr)
1	Paranovus Entertainment Technology	12,507.92 Bn	12,507.92 Bn	-	-
2	Kraft Heinz	27.05 Bn	22.98 Bn	2.22 Bn	-
3	General Mills	17.93 Bn	17.16 Bn	1.37 Bn	-6.10 Mn
4	Jbs	13.56 Bn	8.99 Bn	2.32 Bn	138.42 Mn
5	Hormel Foods	13.29 Bn	12.44 Bn	518.51 Mn	17.23 Mn
6	Mccormick	12.45 Bn	12.85 Bn	708.90 Mn	19.20 Mn
7	Magnum Ice Cream	11.94 Bn	11.47 Bn	-	-
8	J M Smucker	11.83 Bn	11.77 Bn	862.10 Mn	-
9	Smithfield Foods	9.80 Bn	8.73 Bn	511.00 Mn	-2.00 Mn
10	Arcadia Biosciences	1.12 Mn	-3.48 Mn	192,000.00	-

Download Data